Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,289,908 papers from all fields of science
Search
Sign In
Create Free Account
SB-265805
Known as:
SB 265805
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
gemifloxacin
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2001
2001
Comparative in vitro activity of the new quinolone gemifloxacin (SB-265805) with other fluoroquinolones against respiratory tract pathogens.
F. García-Garrote
,
E. Cercenado
,
J. Martín-Pedroviejo
,
Ó. Cuevas
,
E. Bouza
Journal of Antimicrobial Chemotherapy
2001
Corpus ID: 714167
The in vitro activity of gemifloxacin (SB-265805) was compared with that of other fluoroquinolones against 302 clinical isolates…
Expand
2001
2001
In Vitro Activity of Gemifloxacin (SB-265805) Compared to Eleven Other Antimicrobial Agents Against Streptococcal Isolates, Excluding Streptococcus pneumoniae
M. Kerawala
,
J. Ambler
,
P. Y. C. Lee
,
Y. J. Drabu
European Journal of Clinical Microbiology and…
2001
Corpus ID: 28209516
Abstract The purpose of the study presented here was to determine the in vitro activity of gemifloxacin compared with that of 11…
Expand
Highly Cited
2000
Highly Cited
2000
In Vitro Activities of Six Fluoroquinolones against 250 Clinical Isolates of Mycobacterium tuberculosisSusceptible or Resistant to First-Line Antituberculosis Drugs
M. Ruíz-Serrano
,
L. Alcalá
,
+4 authors
E. Bouza
Antimicrobial Agents and Chemotherapy
2000
Corpus ID: 20020862
ABSTRACT Two hundred fifty isolates of Mycobacterium tuberculosis were evaluated for susceptibility to ciprofloxacin, ofloxacin…
Expand
2000
2000
Gemifloxacin Is Effective in Experimental Pneumococcal Meningitis
A. Smirnov
,
A. Wellmer
,
J. Gerber
,
K. Maier
,
S. Henne
,
R. Nau
Antimicrobial Agents and Chemotherapy
2000
Corpus ID: 44463657
ABSTRACT In a rabbit model of Streptococcus pneumoniaemeningitis, 5 mg of gemifloxacin mesylate (SB-265805) per kg/h reduced the…
Expand
2000
2000
In vitro antibacterial activity of gemifloxacin and comparator compounds against common respiratory pathogens.
S. Rittenhouse
,
L. McCloskey
,
+4 authors
K. Coleman
Journal of Antimicrobial Chemotherapy
2000
Corpus ID: 45293407
This study investigated the in vitro potency of the novel quinolone agent gemifloxacin (SB-265805), in comparison with other…
Expand
2000
2000
Bactericidal and bacteriostatic activity of gemifloxacin against Acinetobacter spp. in vitro.
P. Higgins
,
K. Coleman
,
S. Amyes
Journal of Antimicrobial Chemotherapy
2000
Corpus ID: 10047774
This study compared the in vitro bacteriostatic activity of gemifloxacin (SB-265805) and a panel of test antimicrobial agents…
Expand
2000
2000
Development of gemifloxacin in vitro susceptibility test methods for gonococci including quality control guidelines. The Quality Control Study Group.
R. Jones
,
M. Erwin
Diagnostic microbiology and infectious disease
2000
Corpus ID: 25350326
2000
2000
Bactericidal activity of gemifloxacin and other quinolones against Streptococcus pneumoniae.
I. Morrissey
,
J. George
Journal of Antimicrobial Chemotherapy
2000
Corpus ID: 23732205
This study compared the bactericidal activity of gemifloxacin (SB-265805) and a panel of test quinolones against two…
Expand
2000
2000
In vitro activity of gemifloxacin compared with other antimicrobial agents against recent clinical isolates of streptococci.
M. Ieven
,
W. Goossens
,
S. De Wit
,
H. Goossens
Journal of Antimicrobial Chemotherapy
2000
Corpus ID: 15085050
This study investigated the in vitro activity of gemifloxacin (SB-265805) against 50 recent clinical isolates of Streptococcus…
Expand
1999
1999
Studies To Establish Quality Control Ranges for SB-265805 (LB20304) When Using National Committee for Clinical Laboratory Standards Antimicrobial Susceptibility Test Methods
M. Erwin
,
Ronald N. Jones
Journal of Clinical Microbiology
1999
Corpus ID: 82793242
SB-265805, formerly LB20304, is a novel naphthridone compound in the fluoroquinolone class of antimicrobial agents. This…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE